Aptahem
0.85 SEK
-16.06 %
APTA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Aptahem operates in the pharmaceutical industry. The company develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's lead candidate is being developed as an emergency drug intended to prevent the onset of life-threatening organ and tissue damage in patients suffering from sepsis. A large part of the research is carried out in collaboration with partners in the industry. The company was founded in 2014 and is headquartered in Malmö.
Read moreRevenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
Annual report '25
General meeting '26
Aptahem's webinar "Strategic Direction and Planned US Listing" now available
Aptahem Announces English-Language Webinar on Strategic Direction and Planned U.S. Listing
Join Inderes community
Don't miss out - create an account and get all the possible benefits